Haselkorn & Thibaut Investigates Emerson Equity LLC Advisor Patrick Wang Lam

Financial Advisor Lost My Money
Haselkorn & Thibaut, a trusted national investment fraud law firm, has launched an investigation into Patrick Wang Lam (CRD 4723020), a stockbroker registered with Emerson Equity LLC (CRD #130032) in Scottsdale, Arizona. If you’ve worked with Patrick Wang Lam or have concerns about investments recommended by him, this in-depth review covers his background, regulatory record, recent disputes, and what steps impacted investors can take—including how to secure a free consultation with Haselkorn & Thibaut by calling 1-888-994-8066.

Patrick Wang Lam – Advisor Profile Overview

Advisor Name Patrick Wang Lam
CRD Number 4723020
Broker-Dealer Emerson Equity LLC (CRD #130032)
Location Scottsdale, AZ
Industry Experience Since 2004 (multiple brokerage firms listed below)

Employment & Association Background

  • Emerson Equity LLC (Scottsdale, AZ) — Since April 2019
  • Sandlapper Securities, LLC — 10/2018–04/2019
  • J.P. Morgan Institutional Investments Inc. — 12/2017–10/2018
  • Griffin Capital Securities, LLC — 03/2014–10/2017
  • Nationwide Investment Services Corporation — 10/2012–03/2014
  • Ascent Real Estate Securities, LLC — 08/2012–10/2012
  • Lincoln Financial Distributors, Inc. — 12/2010–12/2011
  • SunAmerica Capital Services, Inc. — 01/2007–11/2010
  • MetLife Investors Distribution Company — 09/2004–12/2004; 12/2004–01/2007
  • WM Financial Services, Inc. — 01/2004–08/2004

Other Business Affiliations: Sherer Group, Access Capital Group LLC, Inspired Healthcare Capital, Emerson Bridge Fund I, LLC, Emerson Capital Management, LLC, Mr. Charlies (restaurant franchise), Iota Capital Group.

Recent Complaints and FINRA Arbitration Actions Involving Patrick Wang Lam

While Patrick Wang Lam currently maintains an active registration, and as of today’s public FINRA BrokerCheck and regulatory sources, shows no prior disclosures of criminal, regulatory, or customer-initiated complaints before 2025, a series of customer claims and disputes have emerged recently.

Below is a detailed listing of all recent disputes and their specific allegations:

  • FINRA Arbitration Filed August 2025 (Case No. 25-01596):
    • Claimants allege: breach of contract and warranties, promissory estoppel, violation of consumer protection laws, deceptive trade practices, breach of fiduciary duty, vicarious liability, and violation of Regulation Best Interest (Reg BI)
    • Nature: Real estate securities offerings
    • Damages Sought: $1,000,000 to $5,000,000 (plus interest, fees, and other relief)
  • Another FINRA Arbitration Filed October 2025:
    • Damages Sought: $392,293
    • Allegation: Unsuitable investment recommendations by Mr. Lam
  • Additional Customer Arbitration Filed October 2025:
    • Allegations: Violations of Federal Securities Laws, gross negligence, and violations of the California Securities Act
    • Damages: Not yet specified

Summary of All Publicly Reported Issues and Red Flags

  • Unsuitability Claims: Customers allege that products or strategies recommended were inappropriate for their risk tolerance and investment goals.
  • Breach of Fiduciary Duty: Allegations that the advisor failed to act in the client’s best interest.
  • Misrepresentation & Fraud: Claims of misleading or false information in connection with investment sales.
  • Breach of Contract and Warranties, Promissory Estoppel: Alleged broken promises or agreements related to investment accounts.
  • Consumer-Protection & Securities Statute Violations: Including Regulation Best Interest (Reg BI) and the California Securities Act.

It’s important to note: There are currently no regulatory, criminal, or SEC enforcement actions reported directly against Mr. Lam or Emerson Equity LLC as per the latest public databases. However, the recent FINRA arbitrations reflect growing concerns from multiple customers related to advice and investments handled by Mr. Lam.

Additional Information for Investors

  • Primary Products of Concern: Real estate securities, Delaware Statutory Trust (DST) offerings, Inspired Healthcare Capital investments.
  • Nature of Proceedings: FINRA arbitration is a binding dispute resolution process between investors and their financial advisors or firms. Most cases related to unsuitable recommendations or breaches of duty are resolved here.
  • Potential Recovery: If you have experienced losses handled by Patrick Wang Lam, Haselkorn & Thibaut can advise you about possible remedies and strategies to recover damages through FINRA arbitration.
  • Attorney Fees: Haselkorn & Thibaut operates on a “no recovery, no fee” basis for investor recovery cases. There is no cost unless you recover money.

What Should Affected Investors Do Next?

  • Review Your Accounts: Examine your statements for real estate investments, DSTs, or any products linked to Patrick Wang Lam.
  • Obtain BrokerCheck Reports: For real-time updates on Patrick Wang Lam’s record, visit FINRA BrokerCheck and enter his CRD number: 4723020.
  • Consult an Experienced Law Firm: Haselkorn & Thibaut offers free consultations to investors and has a 98% success rate with over 50 years of combined experience and millions recovered for clients.
  • Act Promptly: Investment-related claims are subject to deadlines. Don’t wait—Review your investments and consider seeking legal advice to protect your potential recovery.

Contact Haselkorn & Thibaut for a Free Consultation

If you have concerns about investment losses, questionable recommendations, or want to discuss your case confidentially, contact Haselkorn & Thibaut at 1-888-994-8066 for a no-cost, no-obligation case review. There are no attorney fees unless a recovery is made on your behalf.

Haselkorn & Thibaut—Helping Investors Nationwide Protect and Recover Their Investments.
Disclaimer: The information contained in any post on this website is derived from publicly available sources and is not guaranteed as to accuracy and often involves allegations which may or may not be proven at some point in the future. All posts are believed to be accurate as of the time of original posting, but the accuracy and details are subject to and expected to change over time and which may contain opinions of the author at the time posted.
Scroll to Top